Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
10 September 2020
PHARMANUTRA S.P.A.: NEW DISTRIBUTION AGREEMENT SIGNED FOR BOLIVIA
08 September 2020
NEW DISTRIBUTION AGREEMENT SIGNED BETWEEN ALESCO AND DELTAGEN UK – ATURA
27 August 2020
THE GROUP KEEPS ON GROWING UNLIKE THE ITALIAN MARKET
20 July 2020
PHARMANUTRA CELEBRATES THREE YEARS SINCE BEING LISTED ON THE AIM ITALIA MARKET
14 July 2020
PHARMANUTRA S.P.A.: REVENUE INCREASES +17% IN THE FIRST HALF OF 2020
17 June 2020
PHARMANUTRA S.P.A.: COMUNICAZIONE AI SENSI DELL’ART. 17 DEL REGOLAMENTO EMITTENTI AIM ITALIA
12 June 2020
AGREEMENT RELATED TO THE PATENT BOX REGIME SIGNED WITH THE REVENUE OFFICE
25 May 2020
PHARMANUTRA S.P.A. TAKES PART IN THE AIM ITALIA CONFERENCE 2020
07 May 2020
CETILAR® OBTAINS PLAY SURE DOPING FREE CERTIFICATION
29 April 2020
PHARMANUTRA S.P.A.:NEW DISTRIBUTION AGREEMENTS IN EUROPE, ASIA AND LATIN AMERICA.
27 April 2020
PHARMANUTRA S.P.A.: ORDINARY SHAREHOLDERS’ MEETING OF 27th APRIL 2020
16 April 2020
PRESENTATION OF PROPOSALS FOR APPOINTMENTS TO THE BOARD OF DIRECTORS OF PHARMANUTRA S.P.A.
<
1
…
9
10
11
…
18
>